Skip to main content

Table 1 General characteristics of the survey participants by the size of participating centers

From: Approach to growth hormone therapy in children with chronic kidney disease varies across North America: the Midwest Pediatric Nephrology Consortium report

  Total (73 responses) Small centers (40 responses) Large centers (33 responses) p-value
Number of pediatric nephrologists per center, median [IQR] 4 [3, 8] 3 [3, 4] 8 [7, 10]  
Number of pediatric nephrologists who were in practice for >10 years, n (%) 25 (34) 10 (25) 15 (45) 0.07
Number of patients receiving rhGH, n (%):     0.02a
 0 7 (9.6) 7 (17.5) 0 (0)
 1–5 44 (60.3) 20 (50.0) 24 (72.73)
  > 5 22 (30.1) 13 (32.5) 9 (27.27)
Number of patients on dialysis, median [IQR] 12 [5, 18] 5.5 [3, 11] 21.5 [13, 32.5] <0.001
  1. aFisher’s exact test, IQR-interquartile range [25%, 75%], rhGH- recombinant human growth hormone. All data are shown per center, except the numbers of patients receiving rhGH, which are shown per nephrologist